Mutual Fund

Fund Card

Shriram Flexi Cap Fund-Reg(G)

very highequityflexi cap fund

20.14 0.01(0.06%) NAV as on 06 Feb 2026

-2.86% 1 M

1.98% 1 Y

10.96% 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

FUND OBJECTIVE

The primary investment objective of the scheme is to generate long term capital appreciation by investing in an actively managed portfolio predominantly consisting of Equity & equity related securities diversified over various sectors.

SCHEME DETAILS

Expenses Ratio :

2.38

As on 31 Jan, 2026

Age :

7 yrs 4 m

Since 28 09 ,2018

Exit Load :

AUM :

131.63 Crs

Lock-in :

NIL for 12% of units and 1% for remaining units on or before 90D, Nil after 90D

Investing Style :

Large Growth

Portfolio Price To Book Value :

5.7

Min. Investment :

SIP 500 & Lumpsum 500

Scheme Benchmark :

Fund Manager :

Deepak Ramaraju,Prateek Nigudkar

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jan 31 ,2026

Others 2.49 %

Equity 97.51 %

TOP HOLDINGS

HDFC Bank Ltd.7.37 %

ICICI Bank Ltd.4.86 %

State Bank Of India4.26 %

Bharti Airtel Ltd.4.01 %

Infosys Ltd.3.52 %

See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Bank - Private	15.72
IT - Software	8.97
Bank - Public	6.81
Refineries	6.56
Hospital & Healthcare Services	4.70

See All Sectors

5-YEARS HISTORY

Financial Year	2021-2022	2022-2023	2023-2024	2024-2025	2025-2026
NAV in Rs (as on 06-Feb-2026)	14.37	14.29	20.16	19.17	20.14
Net Assets(Rs Crores) (as on 06-Feb-2026)	65.15	58.72	83.51	132.67	131.63
Scheme Returns(%)(Absolute)	13.83	-1.25	40.57	-5.85	6.50
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	157/204	15/36	13/39	38/39	34/45

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

No data found

Bank - Private	15.72
IT - Software	8.97
Bank - Public	6.81
Refineries	6.56
Hospital & Healthcare Services	4.70
Telecommunication - Service Provider	4.01
Engineering - Construction	3.95
Automobiles - Passenger Cars	3.91
Pharmaceuticals & Drugs	3.46
Power Generation/Distribution	3.43